Published in Diabetologia (Blher and colleagues, NCT04153929), this Phase 2 trial randomized 413 adults with type 2 diabetes on background metformin to survodutide across several once-weekly or twice-weekly dose groups, to placebo, or to open-label semaglutide up to 1.0 mg once weekly
Recovery peptides like BPC-157 often show improvement within 1-2 weeks
We factor in your current diet, exercise habits, and body composition goals
One treatment round of 10 IVs can lighten your skin to 1 to 3 shades
At 4-6 weeks , the nootropic effects become more robust as users may experience an improved ability to learn, remember, and recall information
Enhanced Mood and Cognitive Function : Alleviate symptoms of brain fog and improve mental clarity